4//SEC Filing
Harsaul Foundation 4
Accession 0001754526-20-000001
CIK 0001739426other
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 4:54 PM ET
Size
5.9 KB
Accession
0001754526-20-000001
Insider Transaction Report
Form 4
Harsaul Foundation
10% Owner
Transactions
- Purchase
Ordinary Shares
2020-01-13$5.00/sh+1,250,000$6,250,000→ 22,485,297 total(indirect: By Self as indirect owner of Altchem Limited)
Footnotes (2)
- [F1]The acquisition of Ordinary Shares reported on this Form 4 (the "Acquired Shares") was made pursuant to an underwritten public offering of Ordinary Shares by Osmotica Pharmaceuticals plc (the "Issuer"). In connection with such offering, the underwriters reimbursed the Issuer for any discounts and commissions payable by the Issuer with respect to the Acquired Shares (the "Discount"). The Issuer in turn paid a fee equal to the amount of the Discount to Altchem Limited totaling $406,250 (the "Fee"), or $0.325 per share. The $5.00 per share price does not reflect payment of the Fee to Altchem Limited.
- [F2]Represents shares of the Issuer held by Altchem Limited. Harsaul Foundation is the indirect owner of Altchem Limited. As a result, Harsaul Foundation may be deemed to share voting and investment power with respect to the shares held by Altchem Limited.
Documents
Issuer
Osmotica Pharmaceuticals plc
CIK 0001739426
Entity typeother
IncorporatedPanama
Related Parties
1- filerCIK 0001754526
Filing Metadata
- Form type
- 4
- Filed
- Jan 14, 7:00 PM ET
- Accepted
- Jan 15, 4:54 PM ET
- Size
- 5.9 KB